Rare diseases
Investigational molecules
Locations
Back to France961 clinical trials in Nice, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Avoiding Anticoagulation with Apixaban for Patients with Intracerebral Hemorrhage
FranceStudy on Maintenance Treatment with Pembrolizumab and Pemetrexed for Stage IV Non-Small Cell Lung Cancer Patients After Initial Chemotherapy and Immunotherapy
FranceStudy on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
FranceStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
FrancePhase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer
FranceEfficacy and safety of remibrutinib (LOU064) in adult patients with papulopustular rosacea: a randomized, double‑blind, placebo‑controlled Phase 2 trial
FrancePhase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis
FranceA Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis
FranceLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
FranceA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
FranceA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
FranceA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on neurodegenerative conditions and movement disorders, including trials evaluating new treatments for Amyotrophic Lateral Sclerosis and Essential Tremor.
Studies aim to improve quality of life and slow disease progression through targeted therapeutic approaches.
Comprehensive research into inflammatory disorders, including studies on Psoriatic Arthritis and innovative treatments for various autoimmune conditions.
Focus on developing targeted therapies and combination treatments for better disease control.
Advanced studies in cancer treatment, particularly focusing on head and neck cancers and innovative approaches in lung cancer therapy.
Investigating combination therapies and targeted treatments for improved patient outcomes.
Groundbreaking research in inflammatory bowel diseases, including novel approaches for Crohn's Disease and Ulcerative Colitis treatment.
Exploring innovative therapeutic strategies and microbiome-based treatments.
Critical research in HIV prevention and treatment, focusing on long-acting preventive medications and innovative therapeutic approaches.
Development of new preventive measures and treatment options for at-risk populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
